Jacinta Toland

Q: What is Jacinta Toland email address?

Email Jacinta Toland at jtoland@baylorgenetics.com. This email is the most updated Jacinta Toland's email found in 2026.

Q: How to contact Jacinta Toland?

To contact Jacinta Toland send an email to jtoland@baylorgenetics.com. (updated on May 05, 2025)

Director, Market Access & Channel Strategy at Baylor Genetics | Philadelphia, Pennsylvania, United States

About Jacinta Toland

Jacinta Toland currently serves as the Director of Market Access & Channel Strategy at Baylor Genetics, where she plays a pivotal role in shaping the company's strategic approach to reimbursement, payer engagement, and market expansion within the rapidly evolving fields of Genetics, Molecular Diagnostics, Oncology, Rare Diseases, and Pharmacogenomics. Her expertise lies in developing comprehensive Market Access operational processes that align with the company's broader business objectives, ensuring seamless integration across cross-functional teams. Jacinta leads the design and implementation of payer coverage and reimbursement strategies, with a particular focus on building robust Payer Account Strategic Frameworks that facilitate effective engagement with national and regional payers, including Medicare A/B MAC and Medicaid programs.

In her current role, Jacinta spearheads the Medicaid Payer Channel strategy, championing innovative approaches to secure payer coverage and access for cutting-edge genetic testing panels and molecular diagnostic solutions. Her deep understanding of healthcare policy, reimbursement landscapes, and coding strategies enables her to navigate complex payer environments effectively. She is also instrumental in establishing Market Access infrastructure, enhancing internal processes for coverage, coding, and payment, which supports Baylor Genetics’ efforts to expand access to transformative diagnostics. Her skills in healthcare policy, payer engagement, and national payer account management position her as a strategic leader committed to advancing patient access and fostering sustainable payer relationships. Through her leadership, Baylor Genetics continues to strengthen its market position by aligning innovative genetic testing solutions with payer expectations and reimbursement frameworks, ultimately driving growth and improving patient outcomes in precision medicine.

Jacinta Toland Work